Hymenoptera Venom Allergy — Acute Care and Immunotherapy

Key Points

• Intramuscular epinephrine is first-line therapy for systemic sting anaphylaxis.
• Remove a retained honeybee stinger promptly; speed is more important than removal technique.
• Large local reactions can be extensive without representing infection or high-risk anaphylaxis.
• Systemic reactions warrant epinephrine access and allergy referral.
• Venom skin testing and serum-specific IgE identify sensitization relevant to venom immunotherapy.
• Severe reactions, especially hypotension or syncope, should prompt consideration of baseline serum tryptase and mast-cell disease.
• Venom immunotherapy is highly effective at preventing severe systemic reactions to future stings.
• VIT duration is individualized, with longer treatment considered in patients at higher relapse or fatality risk.

Algorithm

1. Assess airway, breathing, circulation, skin findings, and whether symptoms are local or systemic.
2. Give IM epinephrine immediately for anaphylaxis and repeat as needed.
3. Provide oxygen, IV fluids, bronchodilator therapy, and airway support according to clinical findings.
4. Remove a retained honeybee stinger promptly and treat the local wound.
5. Observe based on reaction severity, response to epinephrine, comorbidities, and risk of recurrence.
6. At discharge after systemic reaction, provide epinephrine and a written emergency plan.
7. Refer for venom-specific IgE evaluation and consider baseline tryptase after severe reactions.
8. Start venom immunotherapy when systemic reaction history and venom sensitization meet treatment criteria.

Clinical Synopsis & Reasoning

Bee, wasp, yellow-jacket, hornet, and fire-ant stings can cause normal local pain and swelling, large local reactions, isolated cutaneous systemic reactions, or multisystem anaphylaxis. The first clinical decision is whether symptoms remain local or have become systemic. Generalized urticaria, angioedema distant from the sting, bronchospasm, throat tightness, stridor, hypotension, syncope, or gastrointestinal symptoms occurring as part of a multisystem reaction indicate systemic allergy and may meet criteria for anaphylaxis.

A large local reaction can expand over 24 to 48 hours and involve an entire limb. It can look dramatic without representing cellulitis or future high-risk anaphylaxis. Infection is unusual immediately after a sting and should not be diagnosed solely from redness and swelling. In contrast, hypotension, wheeze, laryngeal symptoms, or loss of consciousness are high-risk features that require immediate epinephrine and later allergy evaluation.

For honeybee stings, remove the retained barbed stinger promptly. The speed of removal matters more than whether it is scraped or grasped. Wasps and many other insects typically do not leave a stinger. Inspect for multiple stings because a very large venom burden can cause direct toxic effects even without IgE-mediated allergy.

After a systemic allergic reaction, determine the likely insect, circumstances of exposure, severity, epinephrine requirement, occupational or recreational exposure, and comorbid cardiovascular disease or asthma. Severe reactions, especially hypotension without prominent skin findings, also raise concern for an underlying mast-cell disorder. Baseline serum tryptase is increasingly incorporated into evaluation of patients with severe sting anaphylaxis because elevated baseline tryptase and mast-cell disease are associated with more severe reactions and influence long-term venom immunotherapy decisions.

Treatment Strategy & Disposition

Treat sting anaphylaxis with intramuscular epinephrine in the anterolateral thigh without delay. Repeat dosing if airway, breathing, or circulatory compromise persists. Provide oxygen, airway support, IV access, isotonic fluid for hypotension, and adjunctive bronchodilator therapy for bronchospasm. H1 antihistamines can reduce hives and itching but do not treat laryngeal edema or shock and must not delay epinephrine. Corticosteroids do not replace epinephrine and should not be relied on to prevent a biphasic reaction.

Large local reactions are managed with cold compresses, elevation, oral antihistamines, analgesia, and sometimes a short corticosteroid course when swelling is functionally severe. Antibiotics are not routine unless there is convincing evidence of secondary infection. Multiple stings may warrant evaluation for hemolysis, rhabdomyolysis, kidney injury, or other toxic complications depending on burden and symptoms.

After systemic anaphylaxis, prescribe or provide epinephrine autoinjectors and teach use. Refer to an allergist for venom-specific IgE evaluation by skin testing, serum testing, or both. Testing can occasionally be falsely negative soon after a sting, so a convincing severe history may require repeat testing if the initial study is negative.

Venom immunotherapy is recommended for patients with a systemic sting reaction and demonstrable venom-specific IgE when the future reaction risk is clinically meaningful. It is highly effective, reducing the risk of systemic reaction to subsequent stings to a small fraction of the untreated risk. Children with reactions limited to generalized skin findings often have a low risk of a more severe future event and do not routinely require VIT, while adult cutaneous-only reactions are managed more individually based on exposure, quality of life, and risk tolerance. VIT is commonly continued for 3 to 5 years; longer or indefinite therapy may be considered after very severe initial reactions, mast-cell disease or elevated baseline tryptase, honeybee allergy with high exposure, or other high-risk features.

Epidemiology / Risk Factors

• Stinging insects are an important cause of community anaphylaxis.
• Systemic reactions are more likely to recur in patients with venom-specific IgE and a prior systemic event.
• Large local reactions are common and usually carry a much lower risk of future severe anaphylaxis.
• Adults tend to have a higher risk of severe recurrent sting reactions than children with skin-only systemic reactions.
• Mast-cell disorders and elevated baseline tryptase are associated with more severe sting anaphylaxis.

Investigations

Who Should Receive Immunotherapy

Pharmacology

Prognosis / Complications

• Most acute sting reactions resolve completely with appropriate treatment.
• Untreated venom-allergic patients with prior systemic reactions remain at meaningful risk with future stings.
• Venom immunotherapy reduces systemic reaction risk dramatically and reactions that occur during therapy are usually milder.
• Many patients can stop VIT after 3 to 5 years, but selected high-risk patients benefit from longer treatment.
• Quality of life often improves substantially when patients have a clear emergency plan and effective preventive therapy.

Patient Education / Counseling

• Carry epinephrine and know how and when to use it after a prior systemic reaction.
• Call emergency services after using epinephrine for a severe sting reaction.
• Remove honeybee stingers promptly rather than spending time on a particular scraping technique.
• Use footwear outdoors, caution around open beverages and food, and professional nest removal to reduce exposure.
• Wear medical identification when a prior reaction was severe.
• Keep allergist follow-up if venom immunotherapy is recommended because incomplete treatment may leave substantial residual risk.

Notes

Venom immunotherapy is one of the most effective forms of allergen immunotherapy. The decision is not based on the size of the local swelling but on systemic reaction history, sensitization, future exposure, and severity risk.

Patients often remember the insect incorrectly. Testing and exposure patterns help refine the culprit, but acute treatment never depends on proving whether the sting came from a bee, wasp, or hornet before epinephrine is given.

References

1. AAAAI Stinging Insect Hypersensitivity Practice Parameter — Link
2. AAAAI Stinging Insect Hypersensitivity Practice Parameter — Link